Company intelligence / Profile preview

Hypermol

Bielefeld, North Rhine-Westphalia, Germany

Ownership: Private
Development stage: Other

Overview

Hypermol is a specialized biotechnology company based in Germany that focuses on the production and supply of high-quality proteins and reagents for cytoskeleton research. The company is globally recognized for its expertise in actin and actin-binding proteins, offering an extensive catalog of purified proteins, fluorescently labeled derivatives, and specialized assay kits. Hypermol supports the life science community by providing essential tools for studying cell motility, muscle contraction, and intracellular transport. In addition to its product portfolio, the company offers custom protein purification and biochemical assay development services tailored to academic and industrial research needs.

Modalities: Recombinant proteinBiologicProtein
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Hypermol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hypermol.

Explore the full profile